Medicare Part D
Our Medicare Part D
As the 2023 bid cycle begins, life sciences companies must understand how the Part D market is evolving and how health plans approach Part D formularies and benefit designs. This video series features Avalere leaders with deep expertise on opposing sides of Part D plan/manufacturer formulary negotiations. In the first video of the series, hear from Ryan Urgo and Neil Lund about:
- Membership trends in standalone prescription drug plans and Medicare Advantage prescription drug plans
- The rise in plan spending on specialty drugs in relation to brands and generics
- How these trends impact government payments, plan decision-making, and the push for program reform
Be prepared going into the bid cycle. Our latest content offers a deeper dive into the ins and outs of the Medicare Part D prescription drug benefit.
Our team has the tools and the expertise to guide you through the complexities of Medicare Part D. Our solutions help you chart a path to reach your goals.
Bid Modeling and Analytics
Part D Landscape and Formulary Analysis
Plan Liability and Net Price Estimates
Policy Impact and Scenario Planning
Policy Modeling and Scoring
Pricing, Reimbursement, and Access Strategy